About Bioventus, Inc. 
Bioventus, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 45 Schemes (18.22%)
Foreign Institutions
Held by 66 Foreign Institutions (8.54%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
132 Million
(Quarterly Results - Mar 2026)
Net Profit:
4 Million
Pharmaceuticals & Biotechnology
USD 738 Million (Micro Cap)
54.00
NA
0.00%
1.71
8.27%
4.44






